Monitor the next quarterly filing (10-Q) for any strategic or capital allocation shifts under the new CFO, but this appointment alone is not a trading catalyst.
Price Chart
Executive Summary
Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and CFO, effective October 5, 2026, replacing interim CFO Brent Sabatini. Sawaf brings CFO experience from Theravance Biopharma and a background at Gilead Sciences. This is a routine executive appointment with no financial data or guidance provided.
Key Facts
- Aziz Sawaf appointed EVP and CFO effective October 5, 2026
- Brent Sabatini ceases as interim principal financial officer, remains SVP and CAO
- Sawaf's annualized base salary is $520,000 with a target bonus of 45%
- One-time cash sign-on bonus of $150,000, half on effective date, half after one year
- Equity awards: option for 150,000 shares and RSUs for 75,000 shares, both vesting over four years
- Severance: 12 months base salary plus target bonus in change-in-control termination; 9 months outside change-in-control
Financial Impact
No material financial impact disclosed; executive compensation is standard for a clinical-stage biotech CFO hire.
Risk Factors
- No financial guidance or operational update provided in this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-064117 |
| Document: a2026-10x01_8xkxnewcfoxpre.htm | 0001628280-26-064117 |
| Document: 0001628280-26-064117-index-headers.html | 0001628280-26-064117 |
| Document: 0001628280-26-064117-index.html | 0001628280-26-064117 |
| Document: 0001628280-26-064117.txt | 0001628280-26-064117 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | 3 | $11.93 | awaiting T+5 | awaiting T+5 | $11.75 (−1.51%) |
Oct 28, 2026 1d ago | 8-K | $11.93 | awaiting T+5 | awaiting T+5 | $11.75 (−1.51%) |
Oct 27, 2026 2d ago | SC 13G/A | $11.93 | awaiting T+5 | awaiting T+5 | $11.75 (−1.51%) |
Oct 14, 2026 15d ago | 8-K | $10.41 $10.57 | ▲ +1.54% | ▲ +1.08% | $11.75 (+12.87%) |
Oct 8, 2026 21d ago | 8-K | $11.12 $10.47 | ▼ −5.85% | ▼ −5.57% | $11.75 (+5.67%) |
Oct 6, 2026 23d ago | 3 | $11.60 $10.61 | ▼ −8.53% | ▼ −8.40% | $11.75 (+1.29%) |
Oct 1, 2026 28d ago | 8-K | $11.29 $11.12 | ▼ −1.51% | ▼ −2.81% | $11.75 (+4.07%) |
Sep 23, 2026 5w ago | Court Ruling | $10.72 $11.29 | ▲ +5.32% | ▲ +5.73% | $11.75 (+9.61%) |
Aug 14, 2026 11w ago | Court Ruling | $9.39 $9.91 | ▲ +5.54% | ▲ +6.73% | $11.75 (+25.13%) |
Aug 9, 2026 11w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.75 (+32.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers